---
figid: PMC7383016__CMAR-12-6123-g0001
figtitle: HR pathway in PTEN-deficient EC cells
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Danio rerio
- Arabidopsis thaliana
pmcid: PMC7383016
filename: CMAR-12-6123-g0001.jpg
figlink: pmc/articles/PMC7383016/figure/F0001/
number: F1
caption: Overview of the HR pathway in PTEN-deficient EC cells. When DSBs occur, ATM,
  ATR and CHK1/2 kinases phosphorylate BRCA1, that is stabilized by BARD1. BRCA2,
  whose correct conformation is maintained by DSS1 and PALB2, carries RAD51 to the
  site of DNA damage, where it forms nucleoprotein filaments and stabilizes DNA double
  strands. The EGFR activates PI3K/AKT pathway, that in turn inhibits p53. Conversely,
  PTEN inhibits the PI3K pathway and thus activates p53, that induces cell apoptosis
  and cycle arrest and increases the expression of the RAD51 and the MRN complex (RAD50,
  MRE11, NBS1), involved in the DSBs repair. Moreover, PTEN upregulates RAD51. Therefore,
  mutant PTEN inhibits p53 and RAD51 expression, thus impairing the HR system. Similarly,
  mutant p53 downregulates the MRN complex and RAD51 levels.
papertitle: 'PARP Inhibitors in Endometrial Cancer: Current Status and Perspectives.'
reftext: Lucia Musacchio, et al. Cancer Manag Res. 2020;12:6123-6135.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.969235
figid_alias: PMC7383016__F1
figtype: Figure
redirect_from: /figures/PMC7383016__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7383016__CMAR-12-6123-g0001.html
  '@type': Dataset
  description: Overview of the HR pathway in PTEN-deficient EC cells. When DSBs occur,
    ATM, ATR and CHK1/2 kinases phosphorylate BRCA1, that is stabilized by BARD1.
    BRCA2, whose correct conformation is maintained by DSS1 and PALB2, carries RAD51
    to the site of DNA damage, where it forms nucleoprotein filaments and stabilizes
    DNA double strands. The EGFR activates PI3K/AKT pathway, that in turn inhibits
    p53. Conversely, PTEN inhibits the PI3K pathway and thus activates p53, that induces
    cell apoptosis and cycle arrest and increases the expression of the RAD51 and
    the MRN complex (RAD50, MRE11, NBS1), involved in the DSBs repair. Moreover, PTEN
    upregulates RAD51. Therefore, mutant PTEN inhibits p53 and RAD51 expression, thus
    impairing the HR system. Similarly, mutant p53 downregulates the MRN complex and
    RAD51 levels.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - EGFR
  - CTLA4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - AKT1
  - AKT2
  - AKT3
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - CD274
  - MDM2
  - RAD50
  - MRE11
  - NBN
  - NLRP2
  - TP53
  - TP63
  - TP73
  - ATR
  - ANTXR1
  - MMAB
  - SERPINA2
  - ATM
  - RAD51
  - CHEK2
  - CHEK1
  - BRCA1
  - BRCA2
  - BARD1
  - PALB2
  - SEM1
  - Egf
  - Egfr
  - Ctla4
  - Pik3r1
  - Pten
  - Parp1
  - Akt1
  - Pdcd1
  - Cd274
  - Mdm2
  - Rad50
  - Mre11a
  - Nbn
  - Nlrp2
  - Trp53
  - Atr
  - Mmab
  - Atm
  - Tpm1
  - Rad51
  - Xrcc2
  - Chek2
  - Chek1
  - Brca1
  - Brca2
  - Bard1
  - Palb2
  - Dss1
  - Sem1
  - Prosbeta7
  - ec
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Parp
  - Akt
  - rad50
  - dsb
  - mre11
  - Imp
  - nbs
  - p53
  - betaTub60D
  - hth
  - mei-41
  - put
  - RYa-R
  - tefu
  - CycE
  - cyc
  - Rad51D
  - spn-B
  - spn-A
  - lok
  - grp
  - egf
  - celsr1a
  - egfra
  - ptenb
  - parp14rs2.1
  - si:ch211-241b2.5
  - mdm2
  - nbn
  - tp53
  - atr
  - atm
  - rad51
  - brca2
  - bard1
  - palb2
  - VPS34
  - PD1
  - NBS1
  - H
  - PTEN-deficient
---
